|Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system|
|SECAUCUS, N.J., Dec. 11, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA) charging that the Centers for Medicare & Medicaid Services (CMS) failed to follow a congressional directive to implement a market-based laboratory payment system. Quest is a member of ACLA.
"We fully support the legal a... ||12/11/17|
|Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic|
|Cleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart Disease
SECAUCUS, N.J. and CLEVELAND, Dec. 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on heart disease diagnostics within Cleveland HeartL... ||12/01/17|
|Quest Diagnostics Declares Quarterly Cash Dividend|
|SECAUCUS, N.J., Nov. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on January 24, 2018 to shareholders of record of Quest Diagnostics common stock on January 9, 2018.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived fr... ||11/29/17|
|Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests|
|SECAUCUS, N.J., Nov. 20, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS) publication of finalized 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule (CLFS) pursuant to the Protecting Access to Medicare Act (PAMA) announced November 17, 2017.
"We are... ||11/20/17|